The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA

BACKGROUND: Highly active antiretroviral therapy (HAART) has transformed HIV-1 infection from a deadly disease to a manageable chronic illness, albeit does not provide a cure. The recently developed genome editing system called CRISPR/Cas9 offers a new tool to inactivate the integrated latent HIV-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Weijun, Lei, Rongyue, Le Duff, Yann, Li, Jian, Guo, Fei, Wainberg, Mark A, Liang, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359768/
https://www.ncbi.nlm.nih.gov/pubmed/25808449
http://dx.doi.org/10.1186/s12977-015-0150-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359768/
https://www.ncbi.nlm.nih.gov/pubmed/25808449
http://dx.doi.org/10.1186/s12977-015-0150-z

Ejemplares similares